Fake Medicines ‘A Growing Menace’
The European Union must put tougher measures in place to stamp out the growing problem of trading in counterfeit medicines, a report warns.
Professor David Taylor, of the University of London School of Pharmacy, said the problem had been concentrated in the developing world.
But the global nature of the drugs industry meant patients everywhere were now potentially at risk.
The UK regulator said a vigorous system of checks was already in place.
Some counterfeit medicines have been found to contain toxic substances, such as anti-freeze. Some have small amounts of the active substance, others none at all.
Professor Taylor, whose report is launched on Wednesday at the House of Commons, said increased rationing of drugs could play into the counterfeiters’ hands.
Internet problem
He said: “Compared to the harm done by medicines counterfeiting in Africa and Asia, Europe is relatively safe.
“But there are growing risks, which will get worse if - for example - people believe that they cannot get new medicines that may benefit them for conditions such as cancer, dementia or influenza from publicly funded services.”
World Health Organization statistics indicate 30% of medicines supplied in developing countries are fake.
In East European countries like Russia the proportion is 10%, while in wealthier areas like the UK it less than 1%.
Many of these have been purchased via the internet, but the Medicines and Healthcare Products Regulatory Agency (MHRA) is currently investigating three cases of fake treatments being supplied via the legal NHS medicines supply chain.
Professor Taylor’s report calls for stronger legal penalties for medicine counterfeiting, and better controls over internet pharmacies, and entrepreneurs who trade in medicines.
He said the present system encouraged traders to buy medicines in countries where they are relatively cheap, and sell them on elsewhere at a profit.
While this was not illegal in itself, the fact that it was very difficult to monitor made it potentially attractive to counterfeiters.
Read the rest of this article on the growing problem of fake medicines.
